138 related articles for article (PubMed ID: 32385647)
1. Impact of forced diuresis with furosemide and hydration on the halo artefact and intensity of tracer accumulation in the urinary bladder and kidneys on [
Uprimny C; Bayerschmidt S; Kroiss AS; Fritz J; Nilica B; Svirydenka A; Decristoforo C; di Santo G; von Guggenberg E; Horninger W; Virgolini IJ
Eur J Nucl Med Mol Imaging; 2021 Jan; 48(1):123-133. PubMed ID: 32385647
[TBL] [Abstract][Full Text] [Related]
2. Early Injection of Furosemide Increases Detection Rate of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for
Uprimny C; Bayerschmidt S; Kroiss AS; Fritz J; Nilica B; Svirydenka H; Decristoforo C; von Guggenberg E; Horninger W; Virgolini IJ
J Nucl Med; 2021 Nov; 62(11):1550-1557. PubMed ID: 33712533
[TBL] [Abstract][Full Text] [Related]
3.
Derlin T; Weiberg D; von Klot C; Wester HJ; Henkenberens C; Ross TL; Christiansen H; Merseburger AS; Bengel FM
Eur Radiol; 2016 Dec; 26(12):4345-4353. PubMed ID: 27011373
[TBL] [Abstract][Full Text] [Related]
4. Combination of Forced Diuresis with Additional Late Imaging in
Alberts I; Niklas-Hünermund J; Sachpekidis C; Zacho HD; Mingels C; Dijkstra L; Bohn KP; Läppchen T; Gourni E; Rominger A; Afshar-Oromieh A
J Nucl Med; 2021 Sep; 62(9):1252-1257. PubMed ID: 33547214
[TBL] [Abstract][Full Text] [Related]
5. Impact of forced diuresis at two different time points on pelvic imaging in prostatic carcinoma with 68 Ga-PSMA PET/CT.
Raju S; Sharma A; Kumar S; Seth A; Sharma A; Pandey AK; Kumar R
Nucl Med Commun; 2023 Dec; 44(12):1135-1143. PubMed ID: 37799105
[TBL] [Abstract][Full Text] [Related]
6. Effect of forced diuresis during 18F-DCFPyL PET/CT in patients with prostate cancer: activity in ureters, kidneys and bladder and occurrence of halo artefacts around kidneys and bladder.
Wondergem M; van der Zant FM; Rafimanesh-Sadr L; Knol RJJ
Nucl Med Commun; 2019 Jun; 40(6):652-656. PubMed ID: 30855543
[TBL] [Abstract][Full Text] [Related]
7. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
8. Frusemide aids diagnostic interpretation of
Fennessy N; Lee J; Shin J; Ho B; Ali SA; Paschkewitz R; Emmett L
J Med Imaging Radiat Oncol; 2017 Dec; 61(6):739-744. PubMed ID: 28623852
[TBL] [Abstract][Full Text] [Related]
9. Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study.
Donswijk ML; Wondergem M; de Wit-van der Veen L; Bruin NM; van Leeuwen PJ; van der Poel HG; Stokkel MPM; Vogel WV
EJNMMI Res; 2022 Jul; 12(1):42. PubMed ID: 35895129
[TBL] [Abstract][Full Text] [Related]
10. Determination of optimal
Wen J; Zhu Y; Li L; Liu J; Chen Y; Chen R
Eur J Nucl Med Mol Imaging; 2022 May; 49(6):2086-2095. PubMed ID: 34962583
[TBL] [Abstract][Full Text] [Related]
11. Effects of arm truncation on the appearance of the halo artifact in
Afshar-Oromieh A; Wolf M; Haberkorn U; Kachelrieß M; Gnirs R; Kopka K; Schlemmer HP; Freitag MT
Eur J Nucl Med Mol Imaging; 2017 Sep; 44(10):1636-1646. PubMed ID: 28508120
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Early Imaging and Imaging 60 min Post-Injection after Forced Diuresis with Furosemide in the Assessment of Local Recurrence in Prostate Cancer Patients with Biochemical Recurrence Referred for 68Ga-PSMA-11 PET/CT.
Bayerschmidt S; Uprimny C; Kroiss AS; Fritz J; Nilica B; Svirydenka H; Decristoforo C; von Guggenberg E; Horninger W; Virgolini IJ
Diagnostics (Basel); 2021 Jun; 11(7):. PubMed ID: 34208989
[TBL] [Abstract][Full Text] [Related]
13.
Haupt F; Dijkstra L; Alberts I; Sachpekidis C; Fech V; Boxler S; Gross T; Holland-Letz T; Zacho HD; Haberkorn U; Rahbar K; Rominger A; Afshar-Oromieh A
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):624-631. PubMed ID: 31673789
[TBL] [Abstract][Full Text] [Related]
14. A prospective head-to-head comparison of [
Wang G; Li L; Zhu M; Zang J; Wang J; Wang R; Yan W; Zhu L; Kung HF; Zhu Z
Eur J Nucl Med Mol Imaging; 2023 Aug; 50(10):3126-3136. PubMed ID: 37233785
[TBL] [Abstract][Full Text] [Related]
15. The Clinical Impact of Additional Late PET/CT Imaging with
Afshar-Oromieh A; Sattler LP; Mier W; Hadaschik BA; Debus J; Holland-Letz T; Kopka K; Haberkorn U
J Nucl Med; 2017 May; 58(5):750-755. PubMed ID: 28062595
[TBL] [Abstract][Full Text] [Related]
16. Clinical Translation and First In-Human Use of [
Eppard E; de la Fuente A; Benešová M; Khawar A; Bundschuh RA; Gärtner FC; Kreppel B; Kopka K; Essler M; Rösch F
Theranostics; 2017; 7(18):4359-4369. PubMed ID: 29158832
[TBL] [Abstract][Full Text] [Related]
17. Differential privacy preserved federated transfer learning for multi-institutional
Shiri I; Salimi Y; Maghsudi M; Jenabi E; Harsini S; Razeghi B; Mostafaei S; Hajianfar G; Sanaat A; Jafari E; Samimi R; Khateri M; Sheikhzadeh P; Geramifar P; Dadgar H; Bitrafan Rajabi A; Assadi M; Bénard F; Vafaei Sadr A; Voloshynovskiy S; Mainta I; Uribe C; Rahmim A; Zaidi H
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):40-53. PubMed ID: 37682303
[TBL] [Abstract][Full Text] [Related]
18. SUV
Baiocco S; Matteucci F; Mezzenga E; Caroli P; Di Iorio V; Cittanti C; Bevilacqua A; Paganelli G; Sarnelli A
Mol Imaging Biol; 2020 Aug; 22(4):1070-1077. PubMed ID: 31758510
[TBL] [Abstract][Full Text] [Related]
19. Imaging Characteristics and First Experience of [
Derlin T; Schmuck S; Juhl C; Teichert S; Zörgiebel J; Wester HJ; Schneefeld SM; Walte ACA; Thackeray JT; Ross TL; Bengel FM
Mol Imaging Biol; 2018 Aug; 20(4):650-658. PubMed ID: 29344901
[TBL] [Abstract][Full Text] [Related]
20. Investigation of the halo-artifact in 68Ga-PSMA-11-PET/MRI.
Heußer T; Mann P; Rank CM; Schäfer M; Dimitrakopoulou-Strauss A; Schlemmer HP; Hadaschik BA; Kopka K; Bachert P; Kachelrieß M; Freitag MT
PLoS One; 2017; 12(8):e0183329. PubMed ID: 28817656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
